ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.94471
0.01%
Brent Oil
83.945
0.48%
Bitcoin
58,310.58
0.13%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Krystal Biotech Inc (KRYS)

  7. Krystal Biotech Inc (KRYS) Noticias

KRYS Krystal Biotech Inc

159.67
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Krystal Biotech Inc KRYS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 159.67 06:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
159.67
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:00GLOBEKrystal Biotech to Present at the Association for Research..
26/4/202406:00GLOBEKrystal Biotech to Report First Quarter 2024 Financial..
22/4/202406:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
04/4/202406:00GLOBEKrystal Biotech to Present at the American Association..
01/3/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202420:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202406:00GLOBEKrystal Biotech to Present at TD Cowen 44th Annual Health..
26/2/202412:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202407:04EDGAR2Form 8-K - Current report
26/2/202407:00GLOBEKrystal Biotech Announces Fourth Quarter and Full Year 2023..
26/2/202406:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202406:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202404:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
20/2/202406:00GLOBEKrystal Biotech to Report Fourth Quarter and Full Year 2023 ..
13/2/202406:00GLOBEKrystal Biotech Receives FDA Fast Track Designation for..
08/2/202406:00GLOBEKrystal Biotech Announces Publication in the New England..
01/2/202406:00GLOBEKrystal Biotech to Present at Guggenheim 6th Annual..
24/1/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202410:43EDGAR2Form 144 - Report of proposed sale of securities
04/1/202406:00GLOBEKrystal Biotech Receives Permanent J-code (J3401) for..
19/12/202306:00GLOBEKrystal Biotech Receives Orphan Drug Designation from the..
27/11/202306:00GLOBEKrystal Biotech Announces EMA Validation of Marketing..
09/11/202306:00GLOBEKrystal Biotech to Present at the Stifel 2023 Healthcare..
06/11/202306:10EDGAR2Form 8-K - Current report
06/11/202306:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202306:00GLOBEKrystal Biotech Announces Third Quarter 2023 Financial..
30/10/202306:00GLOBEKrystal Biotech to Report Third Quarter 2023 Financial..
02/10/202311:07EDGAR2Form 144 - Report of proposed sale of securities
28/9/202306:00GLOBEKrystal Biotech to Present at the Chardan 7th Annual Genetic..
07/9/202306:00GLOBEKrystal Biotech to Present at the Morgan Stanley 21st Annual..
05/9/202306:00GLOBEKrystal Biotech Announces Orphan Drug Designation Granted to..
21/8/202316:30EDGAR2Form 144 - Report of proposed sale of securities
16/8/202315:57EDGAR2Form 144 - Report of proposed sale of securities
15/8/202315:56EDGAR2Form 144 - Report of proposed sale of securities
11/8/202315:39EDGAR2Form 144 - Report of proposed sale of securities
10/8/202317:06EDGAR2Form 144 - Report of proposed sale of securities
07/8/202307:18EDGAR2Form 8-K - Current report
07/8/202306:13EDGAR2Form 8-K - Current report
07/8/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202306:00GLOBEKrystal Biotech Announces Second Quarter 2023 Financial..
26/7/202315:14GLOBEKrystal Biotech Announces Pipeline Expansion into Oncology..
26/7/202315:01EDGAR2Form 8-K - Current report
18/7/202315:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
10/7/202315:01GLOBEArbutus Appoints Two New Executives
03/7/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202306:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
05/6/202306:00GLOBEKrystal Biotech to Present at Upcoming Investor Conferences

Su Consulta Reciente

NASDAQ
KRYS
Krystal Biotech
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados